PanaceaStars enables early-stage deep science founders to de-risk their start-up, whilst competing for a prize worth £100K. The Develop stage aims to equip young innovators in the life science and healthcare domains with tailored scientific and business development, legal/IP and fundraising support, and connect them to industry experts for mentorship and feedback.
They welcome ideas at all stages of development that have the potential to impact human health – anything from a therapeutic/diagnostic purpose to a medical device, software application or research platform. They have previously selected finalists with ideas ranging from the very early stage to patent-protected, as well as university start-ups to potential spin-outs. They are also able to endorse a Start-up Visa for any eligible applicants, as they believe that innovation has no borders!
They will be awarding a prize worth £100k, free lab space and ongoing business and legal support to the team with the most exceptional idea. However, they want to stress that the real prize is not the cash. It is the mentoring, networking and skills that they founders will acquire over the course of the programme through interacting with our partners and mentors network, including senior executives from McKinsey and Co, Cancer Research UK, Bio-Rad Laboratories, British Heart Foundation, AstraZeneca, IBM, J A Kemp, Baillie Gifford, and others.
Since its inception in 2016, Panacea Stars has helped 250+ startups with the top 10 performers collectively valued at +£600m. Their best performers are evaluated by Panacea Ventures for investment, either directly or through their expansive network.
They are currently looking for the next bright minds to join us in their SS2023 cohort! Their next application deadline is 19 February at 11.59pm GMT. You can apply online. Don’t miss out on this one of a kind opportunity! If you require further information about the programme, please see their webpage.